Chronic pain and itch are substantial quality-of-life obstacles for patients with the genetic skin disorder recessive dystrophic epidermolysis bullosa (RDEB). RDEB is caused by lossof-function mutations in the anchoring fibril protein type VII collagen. Extreme skin fragility leads to chronic wounds and inflammation that is accompanied by significant pain and itch. Itchy skin has consistently rated as the highest burden in RDEB patients (Danial et al., 2014; van Scheppingen et al., 2008) , and another study found that 93% of dystrophic EB patients experienced itch symptoms (Snauwaert et al., 2014) . Compounding the burden of itching in RDEB, scratching can be associated with new lesions and secondary infection, exacerbating the disease's symptoms and undermining treatment.
(all samples were obtained with written, informed patient consent). All RDEB patients rated itch and pain as at least a 4 ("very bothersome") on the 5-point Likert scale (Danial et al., 2014) , with an average itch rating of 4.5 ± 0.55 and an average pain rating of 4 ± 0 (Supplementary Tables I-II) . Skin biopsies taken from perilesional sites on individuals with RDEB or from healthy controls were stained with antibodies against protein gene product 9.5 (PGP9.5), a pan-neuronal marker commonly used to identify ENFs (Chiang et al., 2011; Kennedy et al., 1996) . PGP9.5-positive nerves within the epidermis were traced in 3-dimensional confocal images (Kennedy et al., 1996) . RDEB patients had significantly fewer ENFs than healthy control subjects. Epidermal innervation decreases with age (Panoutsopoulou et al., 2014) , thus ENF density for each patient was plotted against his or her age. Since epidermal separation during tissue processing is common in RDEB skin, we confirmed that age-dependent ENF densities were reduced in RDEB skin both when considering only unblistered skin regions (Figure 1a ) as well as with all regions included ( Figure 1b) . All RDEB patients also had marked dermal nerve disorganization. Two patients lacked more than 75% of nerve density in the subepidermal neural plexus (SNP) (Figure 1c ) and all patients lacked normal SNP morphology ( Figure 1d ) and bundled nerve structures in the deep dermis fibers (Supplementary Figure S1) . Total PGP9.5 immunofluorescence in the dermis of RDEB patients was significantly reduced over control skin both as a group (Figure 1e ) and as a function of age (Supplementary Figure S2) .
The critical next step is to understand how these morphological peripheral nervous system (PNS) changes arise and impact a patient's sensory experience. In atopic dermatitis (AD), lesional keratinocytes make more nerve growth factor and less of the axonal repellant semaphorin 3A, causing greater ENF densities and itch sensitivity (Tominaga and Takamori, 2014) . While other pruritic and painful conditions have subnormal numbers of ENFs (Caro and Winter, 2014; Kennedy et al., 1996; Maddison et al., 2011; Schuhknecht et al., 2011) , the mechanisms are less well understood. Extended periods of inactivity and systemic opioid analgesia in RDEB may be factors. Abnormal innervation could be associated with fibrotic changes present in RDEB skin. Itching is common in fibrotic scar tissue, and, while increased innervation has been described in hypertrophic scars and animal models (Liang et al., 2004; Zhang and Laato, 2001) , another study found fewer epidermal nerve fibers in itchy keloids (Tey et al., 2012) .
Alternatively, the epidermal hypoinnervation in RDEB, in combination with the lack of visible scarring at the biopsy sites, might be indicative of an intrinsic axonal guidance dysfunction. In support of this hypothesis, proteomic analysis of RDEB extracellular matrix (ECM) has revealed decreased matrix metalloproteinase-2 activity (Kuttner et al., 2013) , which is involved in neuronal growth cone formation (Tominaga et al., 2009) , and decreased basement membrane proteins, including several laminin chains. Laminin-332, the protein absent in the junctional form of EB (JEB), has been shown to inhibit nerve branching as well as neuronal graded potentials in vitro, which is consistent with an increase in ENFs in JEB patients (Chiang et al., 2011) . Therefore, perturbations in ECM homeostasis caused by loss of type VII collagen may dictate sensory pathology in a systemic, developmental fashion rather than through secondary skin injury.
Cutaneous mast cells (MCs) are significant sources of neurotrophic factors such as NGF, and MC-derived tumor necrosis factor-α is required for epidermal hyperinnervation in a rodent model of atopic dermatitis (Kakurai et al., 2006) . MC degranulation alone can trigger pain responses (Chatterjea et al., 2012; Drummond, 2004) and MCs are the most significant source of histamine and other pruritic compounds such as tryptase. To consider their role in RDEB, we quantified MCs in patient biopsies using tryptase immunostaining. Four out of six RDEB biopsies contained significantly more MCs, especially in the upper dermis ( Figure  2a-b) , and half also contained higher amounts of free MC granules (Figure 2c ), which were more localized to the lower dermis (Figure 2a) , in comparison to control skin. Given these findings, an MC stabilizer such as sodium cromolyn (sodium cromoglycate) may be effective for treatment of pain or itch in some patients.
In summary, all RDEB patients in this study had significant peripheral nerve pathology, and 67% (4/6) had increased dermal MC numbers and degranulation. To our knowledge both the pattern of PNS pathology and MC activity in RDEB have not been reported previously, and can serve as a platform for rational identification of effective analgesic and antipruritic treatments in a disease for which they are desperately needed.
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